P28 NewsParagon 28, Inc. Announces Pricing of Initial Public Offering

October 15, 2021by Alysia Ward
Paragon 28 (NYSE: FNA) rings The Opening Bell®

The New York Stock Exchange welcomes Paragon 28 (NYSE: FNA), today, Friday, October 15, 2021, in celebration of its Initial Public Offering. To honor the occasion, Albert DaCosta, President and CEO, and his mother, Amy DaCosta, joined by John Tuttle, NYSE Vice Chairman and Chief Commercial Officer, ring The Opening Bell®.

Photo Credit: NYSE

ENGLEWOOD, Colo.Oct. 15, 2021 /PRNewswire/ — Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. All of the shares are being offered and sold by PARAGON. PARAGON’s common stock is expected to begin trading on the New York Stock Exchange on October 15, 2021, under the ticker symbol “FNA.” The offering is expected to close on October 19, 2021, subject to the satisfaction of customary closing conditions. In addition, PARAGON has granted the underwriters a 30-day option to purchase up to an additional 1,171,875 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

Paragon 28 (NYSE: FNA) rings The Opening Bell®
Photo Credit: NYSE

BofA Securities and Piper Sandler are acting as joint lead book-running managers for the offering. Canaccord Genuity is acting as a lead manager. JMP Securities and Needham & Company are acting as co-managers.

A registration statement relating to the shares being sold in this offering was declared effective by the U.S. Securities and Exchange Commission on October 14, 2021. The offering is being made only by means of a prospectus, copies of which may be obtained from: BofA Securities, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at dg.prospectus_requests@bofa.com; or Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at prospectus@psc.com, or by phone at (800) 747-3924.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Investor Contact:
Gilmartin Group
Matt Bacso, CFA
Matt.bacso@gilmartinir.com

 

Paragon 28 Logo
14445 Grasslands Dr. Englewood, CO 80112

Follow us:

CALL US

The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.

© 2022 Paragon 28, Inc.

Privacy Policy